Short answer: A diketopiperazine (DKP) — more precisely a 2,5-diketopiperazine — is a cyclic dipeptide: two amino acids joined head-to-tail through two amide bonds into a six-membered ring [10]. The parent ring, glycine anhydride (cyclo-Gly-Gly), has the molecular formula C₄H₆N₂O₂ and a molecular weight of about 114.10 g/mol [11]. In the laboratory the same ring is a double-edged thing: it is the core of many bioactive natural products [1], yet it is also one of the most common sequence-dependent side reactions in solid-phase peptide synthesis, where it quietly truncates the growing chain [2][3].
This article is educational analytical and synthetic chemistry for laboratory readers. It does not describe effects in people or animals and is not guidance for human or animal use.
What a diketopiperazine is
A 2,5-diketopiperazine is the ring you get when two amino acids condense through both of their reactive ends instead of forming a straight chain. Andruszkiewicz and co-workers describe 2,5-DKPs plainly as cyclic dipeptides [10]. The simplest example is cyclo(Gly-Gly), listed in PubChem under the names glycine anhydride, 2,5-diketopiperazine and piperazine-2,5-dione, with the formula C₄H₆N₂O₂ and a molecular weight near 114.10 [11]. (For the open-chain two-residue case, see our dipeptide guide; for the amide link itself, see peptide bond.)
Because the ring is small, stable and easy to decorate at two positions, it has attracted sustained interest as a scaffold. Borthwick's comprehensive review in Chemical Reviews is devoted entirely to the synthesis, reactions, medicinal chemistry and bioactive natural products built on the 2,5-diketopiperazine framework [1].
How a DKP forms during peptide synthesis
The reaction that makes synthetic chemists wary is not a planned cyclisation but an unwanted one. Yang and Hansen describe DKP formation as a ubiquitous side reaction in solid-phase peptide synthesis (SPPS): it is essentially a peptide fragmentation in which the free N-terminal amino group (the Nα-group) of the chain attacks the amide or ester carbonyl further back in the backbone, expelling a six-membered diketopiperazine and leaving a shortened, N-terminally truncated peptide [2].
Two features of that description matter in practice:
- It is highly sequence-dependent. Yang and Hansen note that residues with a secondary amino group are extremely prone to drive the reaction, and that it is especially likely when the second amino acid from the N-terminus is proline, a proline analogue, another cyclic secondary-amine amino acid, or an N-alkyl amino acid [2]. Reviewing the older literature, Wang and co-workers note that Rydon and Smith found DKP formation occurs more readily when proline or glycine sits at position 1 or 2, that Gly-Pro cyclises more readily than Pro-Gly, and that Gisin and Merrifield and others flagged Val-Pro, Pro-Pro and Ala-Pro as sensitive sequences [3][4].
- It is usually triggered at the deprotection step. In Fmoc chemistry, DKP formation is predominantly induced at the Fmoc-removal step, which conventionally uses piperidine in dimethylformamide (DMF) [2]. Wang and co-workers add that, once a vulnerable dipeptide has formed, Fmoc deprotection — and therefore DKP formation — can even proceed during post-coupling aging in DMF, DMSO, N-methyl-2-pyrrolidone (NMP) or acetonitrile without any piperidine added at all [3].
Traceless vs visible deletions
Where the DKP forms changes how obvious it is. When it happens in the middle of a sequence, Wang and co-workers explain, the N-terminal nitrogen attacks the carbonyl between the second and third residues, cleaving them off as a DKP and leaving a characteristic des-Xaa-Xaa deletion impurity you can see in the crude product [3]. When it instead removes the C-terminal dipeptide from the resin, Yang and Hansen call it "traceless" DKP formation: the released material washes away, the remaining crude can look highly pure, and the only visible symptom is a reduced yield [2].
What controls the rate
Decades of kinetic work have mapped the levers:
- pH and the state of the amine. Goolcharran and Borchardt studied the model compound Phe-Pro-p-nitroanilide converting to Phe-Pro-DKP and found pseudo-first-order kinetics with a strong pH dependence; the unprotonated N-terminal amine was far more reactive than the protonated form (kinetic pKa about 6.1), and the DKP product itself was stable between pH 3 and 8 but hydrolysed back toward the dipeptide outside that window [5].
- Which residue precedes proline. In the same study, changing the amino acid before the proline significantly changed the rate [5]. Zhang and co-workers later tracked Xaa-Pro-Gly-Lys peptides and found that a charged or polar N-terminal residue sped up cleavage, a nonpolar alkyl side chain left the peptide relatively stable, and aromatic residues gave moderate rates — partly because an aromatic N-terminus favours the cis proline bond needed for the ring to close [8].
- Solvent. Zhang and co-workers also showed, for the peptide FPG₈K, that the rate rises as solvent polarity falls: a lower dielectric constant accelerates the reaction by lowering its enthalpic barrier [9].
- The protein context. Comparing recombinant human vascular endothelial growth factor with short model peptides, Goolcharran and co-workers found the tripeptide Ala-Pro-Met cyclised to its DKP (and its methionine oxidised), and that the DKP reaction ran more slowly in the folded protein than in the free peptide, which they attributed to differences in the cis-trans equilibrium of the X-Pro bond [6].
A link to racemization
DKP formation can also distort stereochemistry studies. Steinberg and Bada heated the dipeptides isoleucyl-glycine and glycyl-isoleucine and found that at pH 6.2 roughly half converted to diketopiperazines, whose hydrolysis can regenerate either the original or a sequence-inverted dipeptide — with the isoleucine the most heavily epimerised component [7]. Their conclusion was blunt: earlier dipeptide racemization studies that ignored DKP formation would need revision [7].
How chemists suppress it
Because the trigger is usually basic Fmoc removal on a vulnerable dipeptide, the fixes aim there:
- Milder or alternative deprotection. Yang and Hansen report that replacing 20% piperidine/DMF with a solution of 2% DBU and 5% piperazine in NMP cut total DKP from 13.8% to 3.6% over two deprotection treatments, while actually speeding Fmoc removal [2].
- Different Nα-protecting groups. They note that groups such as pNZ, trityl and alloc, which avoid base-driven removal, have been used to sidestep the problem [2]. For tirzepatide intermediates, Wang and co-workers found that switching to Bsmoc-protected amino acids eliminated the DKP byproducts, and that adding oxyma and storing at lower temperature markedly improved intermediate stability [3].
- Build-out tricks and timing. Inserting a pre-formed dipeptide building block skips the DKP-prone intermediate [3], and because the reaction keeps going as long as the freed Nα is not yet acylated, Yang and Hansen stress prompt rinsing and coupling after deprotection [2].
Beyond the bench
The same ring that plagues synthesis is widespread in nature and food. Andruszkiewicz and co-workers identified 34 different 2,5-diketopiperazines in cocoa, where they form thermally from short-chain peptide precursors during roasting and contribute to the characteristic bitter taste [10]. And Borthwick's review catalogues the many bioactive natural products built on the DKP scaffold [1].
Diketopiperazine vs related terms
- Diketopiperazine vs dipeptide: a dipeptide is two residues joined by one peptide bond with free ends; a 2,5-DKP is the cyclic form, closed through a second amide bond into a six-membered ring [10][11]. (See dipeptide.)
- Diketopiperazine vs general cyclic peptides: the DKP is the smallest member, a two-residue ring, where larger cyclic peptides close across many residues.
- DKP vs deletion impurity: these are two sides of one event — the DKP is the small ring that leaves, and the des-Xaa-Xaa deletion peptide is what stays behind [3].
- DKP vs deamidation: both are recognised peptide degradation routes, but deamidation changes a side-chain amide to an acid, while DKP formation cleaves the backbone and releases a ring.
Frequently asked questions
What is a diketopiperazine in simple terms?
It is a cyclic dipeptide — two amino acids closed into a six-membered ring through two amide bonds [10]. The simplest, cyclo(Gly-Gly), is also called glycine anhydride [11].
Why does proline cause diketopiperazine formation?
Proline's ring favours the cis amide conformation that lets the N-terminal amine reach back and close the DKP ring, so sequences with proline (or glycine) near the N-terminus cyclise more readily [2][3][8].
At what step of SPPS does DKP formation happen?
Most often at the Fmoc-deprotection step, once a susceptible dipeptide is on the resin; it can also continue during aging before the next residue is coupled [2][3].
Is a diketopiperazine stable once formed?
In one model system the Phe-Pro-DKP was stable between pH 3 and 8 and hydrolysed toward the dipeptide outside that range [5].
Are diketopiperazines only a synthesis problem?
No. They occur naturally and form thermally in foods such as roasted cocoa, where they add bitterness, and they are a scaffold for many natural products [1][10].
Bottom line
A diketopiperazine is the smallest cyclic peptide — a two-residue ring that chemists both prize and fear. As a scaffold it underlies a large family of natural products [1]; as a side reaction it is a sequence-dependent, base-triggered fragmentation that truncates peptides during synthesis and storage, most of all when proline or glycine sits near the N-terminus [2][3]. Knowing the levers — milder deprotection, alternative protecting groups, prompt coupling, controlled pH, solvent and temperature — is what keeps the ring a tool rather than an impurity [2][3][5][9].
All products are for research use only — not for human or animal consumption.